The Buyback That Was Really a Stake Sale: Inside ICG's Amundi Deal

Somewhere on the London Stock Exchange's wires, nearly every working day, a few companies file a press release with the title "Transaction in Own Shares." It is the financial equivalent of a curbside bag check: I, the company, bought this many of my own shares today, at this price, and here is where they are now sitting. Most of the time you can skim it and move on with your life.

ICG plc, the London private-markets asset manager, has been filing these since late February. Read one on its own and it looks like standard capital-return plumbing: buy back your own stock, park it in an account called treasury, cancel the shares in tranches every six months or so. In the week through September 8 it bought 706,778 ordinary shares at around £19 apiece, reported them as held in treasury, and noted that about 6.8 million treasury shares sit there awaiting cancellation. Nothing headline-worthy, right?

That is weird. Because this particular "Transaction in Own Shares" is not really an attempt to return capital to shareholders at all. It is the machinery by which ICG is selling roughly 9.9% of its economics to Amundi, one of Europe's biggest asset managers, while limiting Amundi's voting power to about 4.9% — and the buyback notice is the only part of the whole arrangement you would ever see day to day.

The buyback that is really an issuance

The official story, announced back in November 2025, is a ten-year strategic partnership: Amundi becomes the exclusive distributor in the wealth-investor channel for a set of ICG's private-markets products, and ICG is Amundi's exclusive provider of them. Fine. Deals like that happen all the time.

The odd part is how Amundi pays. It is taking a 9.9% economic interest in ICG, but it does not want — and, for regulatory reasons on both sides, does not want to appear to have — 9.9% of the votes. So the stake is split in two. About 4.64% comes as ordinary voting shares, capped by an ownership limit just under 5%. The rest is a brand-new class of non-voting shares: same dividends, same economic rights as ordinary stock, but zero votes.

To make that work without diluting the existing shareholders who are actually reading these notices, ICG is doing both sides of the trade at once. Before each slug of non-voting shares is issued to Amundi, ICG buys back the same slug of its own ordinary shares on the open market — up to about 5.26% of its issued capital, capped at £316 million. The subscription price for the non-voting shares equals the repurchase price of the ordinary shares in the same tranche, and Amundi reimburses ICG for the costs of running the buyback. Buy a share, issue a share, priced identically.

The cash roughly matches, which is the point. Amundi's subscription money is what funds the repurchase of the exiting holders' stock, and the repurchased ordinary shares get canceled. Net effect for the investors who stick around: their economic share of ICG is about unchanged, and because the ordinary shares they hold are voting and the ones Amundi just got are not, their slice of the votes gets a little bigger. That split shows up in a quirk the partnership documents spell out: a holder whose 1% of economics sits in voting shares commands about 1.06% of the votes.

A partner with economics and no votes

This is a very old instrument wearing a daily-disclosure costume. Non-voting participation shares that carry the dividends but none of the governance are basically ancient preferred-capital. What is newish is using a synchronized on-market buyback to fund and offset the issuance, so a partner's footprint can grow while the governance footprint stays put.

The classification is doing all the work, and the fine print shows exactly where the boundary sits. The non-voting shares are excluded from shareholder-voting notification thresholds and from the UK Takeover Code's mandatory-bid rules, so Amundi's economic stake is largely invisible to the screens that trigger control obligations. And the shares are designed so that if Amundi ever wants to resell them in ways that would spread votes around — a big single transfer, a broad public distribution, a change of control — they convert into ordinary voting shares at that moment. Capped at 4.9% while they sit there; fully capable of voting if they leave the wrapper. Amundi also agreed to a rolling two-year lock-up, and can grow its total economic interest up to 14.9% over time, so long as the voting cap holds.

So what should a US investor actually take from a headline nobody ever assigned a second thought to? Two things. First, for ICG specifically: this buyback is not a "management thinks the stock is cheap" signal, and it is only incidentally a shrinking of the share count. It is a distribution deal wrapped around financing — Amundi is effectively paying market price to become a big, vote-less, locked-in economic owner and distribution partner. Amundi gets no discount and existing holders get no stealth dilution on economics; the whole machine exists to keep those two truths true at once.

Second, the general lesson, because this form of disclosure is commoditized and easy to skim past: when you read "Transaction in Own Shares," do not default to the corporate-finance textbook. Ask who is on the other side of the buyback and what classification is doing the work. A repurchase can return cash, or it can be the plumbing for a partnership, a control cap, or a financing that the headline would never tell you about. The share count is the boring part. The votes are the story.